Authors:
Munck, A
Bonacorsi, S
Mariani-Kurkdjian, P
Lebourgeois, M
Gerardin, M
Brahimi, N
Navarro, J
Bingen, E
Citation: A. Munck et al., Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization, PEDIAT PULM, 32(4), 2001, pp. 288-292
Authors:
Rolon, MA
Benali, K
Munck, A
Navarro, J
Clement, A
Tubiana-Rufi, N
Czernichow, P
Polak, M
Citation: Ma. Rolon et al., Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy, ACT PAEDIAT, 90(8), 2001, pp. 860-867
Authors:
Berriot-Varoqueaux, N
Dannoura, AH
Moreau, A
Verthier, N
Sassolas, A
Cadiot, G
Lachaux, A
Munck, A
Schmitz, J
Aggerbeck, LP
Samson-Bouma, ME
Citation: N. Berriot-varoqueaux et al., Apolipoprotein B48 glycosylation in abetalipoproteinemia and Anderson's disease, GASTROENTY, 121(5), 2001, pp. 1101-1108
Citation: P. Marteau et al., Management of digestive and nutritional disorders in adults with cystic fibrosis, REV MAL RES, 17(3BIS), 2000, pp. 785-797
Authors:
Bloch, J
Chavance, M
Lellouch, J
Tahri, N
Munck, A
Malbezin, S
Citation: J. Bloch et al., Use of GEE for modeling censored correlated data: application to the studyof risk factors for withdrawal of totally implantable vascular access devices in cystic fibrosis, REV EPIDEM, 47(6), 1999, pp. 585-591
Authors:
Debray, D
Lykavieris, P
Gauthier, F
Dousset, B
Sardet, A
Munck, A
Laselve, H
Bernard, O
Citation: D. Debray et al., Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension, J HEPATOL, 31(1), 1999, pp. 77-83